These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23499926)

  • 21. Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin.
    Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
    Immunobiology; 2011 Jun; 216(6):698-706. PubMed ID: 21183243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
    Atassi MZ; Dolimbek BZ; Jankovic J; Steward LE; Aoki KR
    Immunobiology; 2011 Jul; 216(7):782-92. PubMed ID: 21281977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A.
    Corbett CR; Ballegeer E; Weedmark KA; Elias MD; Al-Saleem FH; Ancharski DM; Simpson LL; Berry JD
    Hybridoma (Larchmt); 2011 Dec; 30(6):503-10. PubMed ID: 22149274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.
    Phalipon A; Folgori A; Arondel J; Sgaramella G; Fortugno P; Cortese R; Sansonetti PJ; Felici F
    Eur J Immunol; 1997 Oct; 27(10):2620-5. PubMed ID: 9368618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
    Dolimbek BZ; Aoki KR; Steward LE; Jankovic J; Atassi MZ
    Mol Immunol; 2007 Feb; 44(5):1029-41. PubMed ID: 16647121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
    Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
    Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
    Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
    Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
    Atassi MZ; Dolimbek BZ; Jankovic J; Steward LE; Aoki KR
    Mol Immunol; 2008 Sep; 45(15):3878-88. PubMed ID: 18676021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A.
    Yu YZ; Ma Y; Chen YX; Gong ZW; Wang S; Yu WY; Sun ZW
    Hum Vaccin; 2011 Oct; 7(10):1090-5. PubMed ID: 21941093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins.
    Schreiber A; Humbert M; Benz A; Dietrich U
    J Comput Chem; 2005 Jul; 26(9):879-87. PubMed ID: 15834923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology.
    Timmerman P; Puijk WC; Meloen RH
    J Mol Recognit; 2007; 20(5):283-99. PubMed ID: 18074397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
    Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the principal protective antigenic determinants of type A botulinum neurotoxin.
    Bavari S; Pless DD; Torres ER; Lebeda FJ; Olson MA
    Vaccine; 1998 Nov; 16(19):1850-6. PubMed ID: 9795391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.
    Gray SA; Barr JR; Kalb SR; Marks JD; Baird CL; Cangelosi GA; Miller KD; Feldhaus MJ
    Biotechnol Bioeng; 2011 Oct; 108(10):2456-67. PubMed ID: 21538339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide.
    Feng YK; Yang QH; Liu YS; Xu JC; Qian GS; Wang YH
    J Immunol Methods; 2010 Oct; 362(1-2):60-9. PubMed ID: 20833181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selecting highly structure-specific antibodies using structured synthetic mimics of the cystine knot protein sclerostin.
    Back JW; Frisch C; Van Pee K; Boschert V; van Vught R; Puijk W; Mueller TD; Knappik A; Timmerman P
    Protein Eng Des Sel; 2012 May; 25(5):251-9. PubMed ID: 22454505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system.
    Villaflores OB; Hsei CM; Teng CY; Chen YJ; Wey JJ; Tsui PY; Shyu RH; Tung KL; Yeh JM; Chiao DJ; Wu TY
    J Virol Methods; 2013 Apr; 189(1):58-64. PubMed ID: 23313783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic peptides selected by phage display mimic the natural epitope recognized by a monoclonal anti-colicin A antibody.
    Coulon S; Metais JY; Chartier M; Briand JP; Baty D
    J Pept Sci; 2004 Nov; 10(11):648-58. PubMed ID: 15568679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.
    Lou J; Wen W; Conrad F; Meng Q; Dong J; Sun Z; Garcia-Rodriguez C; Farr-Jones S; Cheng LW; Henderson TD; Brown JL; Smith TJ; Smith LA; Cormier A; Marks JD
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29462889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
    Dolimbek GS; Dolimbek BZ; Aoki KR; Atassi MZ
    Immunol Invest; 2005; 34(2):119-42. PubMed ID: 15921155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.